Literature DB >> 24467292

Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors.

Marcio F Chedid1, Charles B Rosen, Scott L Nyberg, Julie K Heimbach.   

Abstract

BACKGROUND: Although increasing donor age adversely affects survival after liver transplantation, livers have been used from selected deceased donors older than 70 years. Although there are reports of excellent short-term results, long-term results are unknown. Our experience was reviewed with septuagenarian and octogenarian deceased donors to determine long-term outcomes.
METHODS: All primary deceased donor liver transplants performed at our institution between July 1998 and December 2010 were reviewed. Recipients of livers procured after circulatory arrest, split and reduced-size livers and multiple organ transplants were excluded from the study. Patient and graft survival were calculated using the Kaplan-Meier method, and survival comparisons were made with the log-rank test.
RESULTS: In total, 780 patients met inclusion criteria, and 109 patients received livers from donors older than 70 years (range = 70-86). There were no differences in long-term patient (P = 0.67) or graft (P = 0.42) survival between hepatitis C negative recipients of livers from older compared with younger donors. In contrast, 7-year survival for HCV-positive recipients of older donor livers was less than half that of HCV-negative recipients. DISCUSSION: Transplantation of livers from septua- and octogenarian donors can achieve excellent long-term patient and graft survival for selected HCV-negative patients.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 24467292      PMCID: PMC4159459          DOI: 10.1111/hpb.12221

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  23 in total

1.  Use of octogenarian livers safely expands the donor pool.

Authors:  C Jiménez Romero; E Moreno González; F Colina Ruíz; F Palma Carazo; C Loinaz Segurola; F Rodríguez González; I González Pinto; I García García; D Rodríguez Romano; C Moreno Sanz
Journal:  Transplantation       Date:  1999-08-27       Impact factor: 4.939

Review 2.  Predicting outcome after liver transplantation.

Authors:  W J Wall
Journal:  Liver Transpl Surg       Date:  1999-09

3.  A revised consideration on the use of very aged donors for liver transplantation.

Authors:  G L Grazi; M Cescon; M Ravaioli; G Ercolani; F Pierangeli; A D'Errico; L Ridolfi; A Cavallari; A Mazziotti
Journal:  Am J Transplant       Date:  2001-05       Impact factor: 8.086

4.  Safe use of hepatic allografts from donors older than 70 years.

Authors:  S Emre; M E Schwartz; G Altaca; P Sethi; M I Fiel; S R Guy; D M Kelly; A Sebastian; A Fisher; D Eickmeyer; P A Sheiner; C M Miller
Journal:  Transplantation       Date:  1996-07-15       Impact factor: 4.939

5.  Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers.

Authors:  R Adam; C Sanchez; I Astarcioglu; H Bismuth
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

6.  Liver transplantation using elderly donors: a risk factor analysis.

Authors:  Dae Y Kim; Jang Moon; Eddie R Island; Akin Tekin; Susan Ganz; David Levi; Gennaro Selvaggi; Seigo Nishida; Andreas G Tzakis
Journal:  Clin Transplant       Date:  2011 Mar-Apr       Impact factor: 2.863

7.  The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival.

Authors:  J Busquets; X Xiol; J Figueras; E Jaurrieta; J Torras; E Ramos; A Rafecas; J Fabregat; C Lama; L Ibañez; L Llado; J M Ramon
Journal:  Transplantation       Date:  2001-06-27       Impact factor: 4.939

8.  Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation.

Authors:  M Deschênes; C Forbes; J Tchervenkov; J Barkun; P Metrakos; J Tector; E Alpert
Journal:  Liver Transpl Surg       Date:  1999-09

9.  Liver transplantation from donors aged 80 years and over: pushing the limit.

Authors:  Bruno Nardo; Michele Masetti; Lucio Urbani; Paolo Caraceni; Roberto Montalti; Franco Filipponi; Franco Mosca; Gerardo Martinelli; Mauro Bernardi; Antonio Daniele Pinna; Antonino Cavallari
Journal:  Am J Transplant       Date:  2004-07       Impact factor: 8.086

10.  Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.

Authors:  M Wali; R F Harrison; P J Gow; D Mutimer
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

View more
  7 in total

1.  Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.

Authors:  Marcio F Chedid
Journal:  Dig Dis Sci       Date:  2017-10       Impact factor: 3.199

Review 2.  The dawn of liver perfusion machines.

Authors:  Danielle Detelich; James F Markmann
Journal:  Curr Opin Organ Transplant       Date:  2018-04       Impact factor: 2.640

3.  Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.

Authors:  Simone Lanini; Alessandro Nanni Costa; Paolo A Grossi; Francesco Procaccio; Andrea Ricci; Maria R Capobianchi; Norah A Terrault; Giuseppe Ippolito
Journal:  Liver Int       Date:  2015-09-21       Impact factor: 5.828

4.  Hypothermic machine perfusion with metformin-University of Wisconsin solution for ex vivo preservation of standard and marginal liver grafts in a rat model.

Authors:  Yi-Chao Chai; Guo-Xin Dang; Hai-Qi He; Jian-Hua Shi; Hong-Ke Zhang; Rui-Tao Zhang; Bo Wang; Liang-Shuo Hu; Yi Lv
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

5.  Octogenarian liver grafts: Is their use for transplant currently justified?

Authors:  Carlos Jiménez-Romero; Felix Cambra; Oscar Caso; Alejandro Manrique; Jorge Calvo; Alejandro Marcacuzco; Paula Rioja; David Lora; Iago Justo
Journal:  World J Gastroenterol       Date:  2017-05-07       Impact factor: 5.742

6.  Optimizing the Use of Geriatric Livers for Transplantation in the Eurotransplant Region.

Authors:  Jacob D de Boer; Joris J Blok; Hein Putter; Jacob J E Koopman; Bart van Hoek; Undine Samuel; Marieke van Rosmalen; Herold J Metselaar; Ian P J Alwayn; Markus Guba; Andries E Braat
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

7.  Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers.

Authors:  Sebastian Pratschke; Hannah Arnold; Alfred Zollner; Michael Heise; Andreas Pascher; Peter Schemmer; Marcus N Scherer; Andreas Bauer; Karl-Walter Jauch; Jens Werner; Markus Guba; Martin K Angele
Journal:  Transplant Direct       Date:  2016-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.